Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 22 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
11/13/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189290697&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 189290697 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 11/13/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 189290697 10.1186/s13058-025-02163-x 189290697 ppf: 1 ppct: 21 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer. aug: au: Jouines, Camille Lo Monaco, Piero Gaucherot, Angéline Radermecker, Julie Isaac, Caroline Bourdelais, Fleur Monet, Marie-Ambre Meyer, Marion Chalabi-Dchar, Mounira Nguyen Van Long, Flora Baillon, Laury Froment, Carine Marcoux, Julien Vanbelle, Christophe Fenouil, Tanguy Durand, Sébastien Giraud, Stéphane Diaz, Jean-Jacques Marcel, Virginie Catez, Frédéric affil: https://ror.org/02mgw3155 Ribosome, Translation and Cancer Team, LabEx DEVweCAN, Institut Convergence Plascan, LyriCAN+, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|